None listed
Conditions
Interventions
Peripheral refraction instrument - mode of operation. Participants will be recruited over a period of 5 months. Participants will be asked to attend the clinic for up to five visits. Each visit will take up to 1 hour. During these visits central and peripheral refraction measurements will be performed using up to three different instruments, the EyeMapper which is a novel peripheral refraction instrument, the Shin Nippon NVision K5001, a commercially available open view autorefractor and the COAS, a commercially available aberrometer.
Sponsors
Eligibility
Inclusion criteria
Participants enrolled in the trial must be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent and must be at least 18 years old.
Exclusion criteria
Participants enrolled in the trial must not been currently enrolled in another clinical trial and must not have manifest strabismus or any anterior eye anomalies.